Dr Reddys Laboratories RDY
NYSE RDY
$15.07 +0.16 (+1.07%)
As of: Nov 9, 2026 · 1:34 PM EST

Dr Reddys Laboratories (RDY) Interest & Investment Income (2009 - 2026)

Updated

Dr Reddys Laboratories (RDY) recorded Interest & Investment Income of $9.61 million in fiscal Q2 2027 (quarter ended Sep 30, 2026), down 50.1% from $19.27 million a year earlier and down 69.5% from the prior quarter.

Analysis

Dr Reddys Laboratories (RDY) Interest & Investment Income (2009 - 2026) Analysis & Trends

On a TTM basis, Dr Reddys Laboratories' Interest & Investment Income came in at $83.25 million as of Sep 30, 2026, down 9.0% year-over-year; for FY2026 (ended Mar 31, 2026), it was $84 million, down 4.5% from FY2025.

  • Annual Interest & Investment Income has a five-year compound annual growth rate of 18.5% (FY2021 to FY2026).
  • Across earlier fiscal years, Interest & Investment Income came in at $88 million in FY2025 (+29.4%), $68 million in FY2024 (+30.8%), $52 million in FY2023 (+26.8%) and $41 million in FY2022 (+13.9%).
  • The fiscal Q2 2027 figure is the lowest quarterly Interest & Investment Income since fiscal Q3 2025.
  • On a year-over-year basis, Interest & Investment Income rose in four of the last eight quarters, with growth averaging 17.0%.
  • Peak year-over-year performance for Interest & Investment Income in the last five years was growth of 894.7% in fiscal Q2 2024, against a decline of 59.8% in fiscal Q1 2024 at the low end.
  • Per Business Quant, the preceding three fiscal quarters came in at $31.57 million (Q1 2027), $18.34 million (Q4 2026) and $23.72 million (Q3 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Eli Lilly 1,257.32 Bn 1,230.94 Bn 20.46 Bn -
2 Johnson & Johnson 680.81 Bn 600.67 Bn 17.30 Bn 186.00 Mn
3 AbbVie 520.51 Bn 488.52 Bn 13.12 Bn -
4 Merck 366.45 Bn 329.39 Bn 13.19 Bn -
5 Novartis Ag 317.39 Bn 290.63 Bn - -
6 Astrazeneca 294.50 Bn 268.39 Bn 13.26 Bn 67.00 Mn
7 Amgen 251.76 Bn 203.42 Bn 7.58 Bn -
8 Gilead Sciences 210.60 Bn 185.71 Bn 6.73 Bn -
9 Pfizer 168.24 Bn 115.60 Bn 12.56 Bn -
10 Dr Reddys Laboratories 12.54 Bn 11.89 Bn 472.93 Mn 9.61 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 9.61 Mn
Jun 30, 2026 31.57 Mn
Mar 31, 2026 18.34 Mn
Dec 31, 2025 23.72 Mn
Sep 30, 2025 19.27 Mn
Jun 30, 2025 28.04 Mn
Mar 31, 2025 34.74 Mn
Dec 31, 2024 9.45 Mn
Sep 30, 2024 27.60 Mn
Jun 30, 2024 17.20 Mn
Mar 31, 2024 19.45 Mn
Dec 31, 2023 16.30 Mn
Sep 30, 2023 19.09 Mn
Jun 30, 2023 14.06 Mn
Mar 31, 2023 14.03 Mn
Dec 31, 2022 3.40 Mn
Sep 30, 2022 1.92 Mn
Jun 30, 2022 34.96 Mn
Mar 31, 2022 15.63 Mn
Dec 31, 2021 -11.00 Mn
API Access

Dr Reddys Laboratories Interest & Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=RDY&period=max&api_key=YOUR_API_KEY